We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
There have been important advances in the last few years in the study of the mechanisms involved in the presentation of the different forms of asthma.
Specifically, research is being carried out in order to determine the so-called asthma phenotypes. A phenotype refers to certain patient groups with asthma that have similar clinical and inflammatory characteristics. Research is currently being carried out to study the phenotypes better and find more personalised treatments for the patients.
Research into new treatments. The advances in the understanding of the disease have led to the development of new drugs with novel mechanisms of action involved in the inflammatory airways of the asthma. It is the case of the so-called biological drugs, which are monoclonal antibodies that act by blocking certain proteins involved in development of asthma. Multicentre studies are currently being conducted on patients in order to test their effectiveness and safety and that will very likely be available in the future to treat this type of patient. Some examples of these are:
Antibodies against ILE: Quilizumab.
Antibodies against IL5: Benralizumab, Reslizumab.
Antibodies against IL13: Lebrikizumab, Tralokinumab.
We are sorry, we are working to improve PortalCLÍNIC. Help us become better, tell us why
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Alejandra Lopez GiraldoPneumologistPneumology and Allergy Department
Antonio Valero SantiagoAllergistPneumology and Allergy Department
Irina BoboleaAllergistPneumology and Allergy Department
Rosa Cortés AguilarNursePneumology and Allergy Department
Published: 20 February 2018
Updated: 20 February 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.